1. Home
  2. LEGN vs XP Comparison

LEGN vs XP Comparison

Compare LEGN & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$19.07

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Logo XP Inc.

XP

XP Inc.

N/A

Current Price

$18.07

Market Cap

10.1B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LEGN
XP
Founded
2014
2001
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
10.1B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
LEGN
XP
Price
$19.07
$18.07
Analyst Decision
Buy
Strong Buy
Analyst Count
14
6
Target Price
$63.08
$22.67
AVG Volume (30 Days)
1.7M
6.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.90%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$46.27
$19.15
Revenue Next Year
$28.77
$13.67
P/E Ratio
N/A
$11.42
Revenue Growth
N/A
N/A
52 Week Low
$16.24
$12.20
52 Week High
$45.30
$23.13

Technical Indicators

Market Signals
Indicator
LEGN
XP
Relative Strength Index (RSI) 51.45 40.23
Support Level $17.46 $18.05
Resistance Level $23.68 $20.37
Average True Range (ATR) 0.95 1.00
MACD 0.22 -0.36
Stochastic Oscillator 41.87 2.55

Price Performance

Historical Comparison
LEGN
XP

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.

Share on Social Networks: